Metabolic reprogramming of methylthioadenosine-dependent sulfur recycling is a major driver of CHIKV infection
Muema, J. M.; Friemelt, M.; Overwin-Moser, H.; Beutling, U.; Franke, R.; Broenstrup, M.; Sandner, P.; Bilitewski, U.
Show abstract
The supply of key metabolites into viral replication compartments must be assured through a coordinated reprogramming of host metabolic pathways. For chikungunya virus (CHIKV), the cellular metabolites required for a successful infection are largely unknown. We show that CHIKV reprograms sulfur-dependent pathways. To maintain the resupply of thiols, the methionine (Met) salvage players, 5'-methylthioadenosine (MTA) and methionine adenosyltransferase-2a (Mat2a) are co-induced specifically. Under sulfur-depleted conditions, exogenously added MTA restores CHIKV replication more efficiently than its precursor S-adenosylmethionine, while inhibitions of Mat2a or de novo cysteine (Cys) biosynthesis reduce viral infectivity. Upon sulfur insufficiency CHIKV upregulates the U34-tRNA methyltransferase ALKBH8, and when ALKBH8 is deleted, virus replication is reduced by impairing sulfur relay, recapitulating Met-Cys deprivation effects. We found that MTA-mediated CHIKV replication occurs via m6A-independent priming, and that the S-adenosylhomocysteine hydrolase inhibitors DzNep and Adox, inhibited CHIKV replication with nanomolar potency. Our findings uncovered a major pro-CHIKV metabolic rheostat regulating tRNA modifications that can be targeted with host-directed antiviral agents.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Comparative multiplexed interactomics of SARS-CoV-2 and homologous coronavirus non-structural proteins identifies unique and shared host-cell dependencies 94%
- Cysteine reactivity profiling identifies host regulators of Mycobacterium tuberculosis replication in human macrophages 94%
- Immunogenicity and protective efficacy of a highly thermotolerant, trimeric SARS-CoV-2 receptor binding domain derivative 94%
Similar papers in this journal
- DAZAP2 functions as a pan-coronavirus restriction factor by inhibiting viral entry and genomic replication 96%
- Evolutionary and phenotypic characterization of spike mutations in a new SARS-CoV-2 Lineage reveals two Variants of Interest 95%
- JIB-04 has broad-spectrum antiviral activity and inhibits SARS-CoV-2 replication and coronavirus pathogenesis 94%
Similar papers in this journal
- Ethacridine inhibits SARS-CoV-2 by inactivating viral particles in cellular models 95%
- Inducible CRISPR activation screen for interferon-stimulated genes identifies OAS1 as a SARS-CoV-2 restriction factor 95%
- Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses 95%
Similar papers in this journal
- Mechanistic Insights into Dengue Virus Inhibition by a Clinical Trial Compound NITD-688 97%
- 2-Thiouridine is a broad-spectrum antiviral nucleoside analogue against positive-strand RNA viruses 97%
- Whole Virion Proteomics of HCMV Reveals that gpUL141 is a Virion Component that Regulates Envelope Glycoprotein Composition to Protect Against Humoral Immunity 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.